AYER -- Nashoba Valley Medical Center, a Steward family hospital, will be a part of Civica Rx, a new, innovative effort to ensure essential generic medications are available, affordable and accessible to all.
Civica Rx is a collaborative not-for-profit generic drug company whose mission is to drive down costs and increase supply of life-saving medicines.
Nashoba Valley Medical Center's participation in the initiative is made possible thanks to the hospital being part of Steward Health Care, the largest privately operated health care network in the United States, and a founding member of Civica Rx.
Nashoba Valley Medical Center and Steward Health Care join prominent health systems, including Mayo Clinic and HCA Healthcare, to sign on with Civica.
Overall, approximately 800 U.S. hospitals have joined the venture, with many more health systems expressing interest. Through a collaborative approach, the partnership will identify the production needs of in-demand drugs and develop high-quality FDA approved medications at affordable prices, closing gaps in the drug marketplace.
"Nashoba Valley Medical Center and Steward are proud to join Civica because a new, highly collaborative, approach is needed to solve America's drug shortage crisis," said Dr. Joseph Weinstein, chief medical officer of Steward Health Care. "Over the past decade, Steward has created a different kind of health-care company, one that prioritizes wellness and unlocks access to high-quality, affordable care -- which aligns with the critically important mission of Civica.
"We are thrilled to welcome these highly regarded health systems to Civica as founding members," said Civica Rx CEO Martin VanTrieste. "Drug shortages have become a national crisis where patient treatments and surgeries are canceled, delayed or suboptimal. We thank these organizations for joining us to make essential generic medicines accessible and affordable in hospitals across the country."
Civica Rx expects to bring over 14 hospital-administered generic drugs to hospitals and health-care systems in 2019 as the initial focus of the company's efforts, with many additional medications prioritized by the health-care systems as the next phase of focus for the company.